NYSE:PACS PACS Group (PACS) Stock Price, News & Analysis $10.83 -0.41 (-3.65%) Closing price 03:59 PM EasternExtended Trading$11.05 +0.22 (+1.99%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About PACS Group Stock (NYSE:PACS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PACS Group alerts:Sign Up Key Stats Today's Range$10.61▼$11.3250-Day Range$10.83▼$14.5452-Week Range$10.61▼$43.92Volume615,342 shsAverage Volume819,238 shsMarket Capitalization$1.65 billionP/E RatioN/ADividend YieldN/APrice Target$34.00Consensus RatingModerate Buy Company OverviewPACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.Read More… Remove Ads PACS Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScorePACS MarketRank™: PACS Group scored higher than 77% of companies evaluated by MarketBeat, and ranked 235th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingPACS Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoveragePACS Group has only been the subject of 2 research reports in the past 90 days.Read more about PACS Group's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth76.24% Earnings GrowthEarnings for PACS Group are expected to grow by 76.24% in the coming year, from $1.01 to $1.78 per share.Price to Earnings Growth RatioPACS Group has a PEG Ratio of 0.49. PEG Ratios below 1 indicate that a company could be undervalued. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.72% of the float of PACS Group has been sold short.Short Interest Ratio / Days to CoverPACS Group has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in PACS Group has recently decreased by 9.43%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPACS Group does not currently pay a dividend.Dividend GrowthPACS Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.72% of the float of PACS Group has been sold short.Short Interest Ratio / Days to CoverPACS Group has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in PACS Group has recently decreased by 9.43%, indicating that investor sentiment is improving significantly. News and Social Media2.0 / 5News Sentiment0.55 News SentimentPACS Group has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for PACS Group this week, compared to 18 articles on an average week.Search InterestOnly 1 people have searched for PACS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added PACS Group to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PACS Group insiders have not sold or bought any company stock.Read more about PACS Group's insider trading history. Receive PACS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PACS Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PACS Stock News HeadlinesMusk-funded political group spends big and goes door to door in Wisconsin Supreme Court raceApril 1 at 12:42 PM | msn.comPro-marijuana group aims to sway Trump by airing ads around White House and Mar-a-LagoApril 1 at 12:42 PM | msn.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 1, 2025 | Porter & Company (Ad)PACS Group Inc options imply 6.6% move in share price post-earningsMarch 31 at 9:40 PM | msn.comMusk-funded political group spends big and goes door to door in the Wisconsin Supreme Court raceMarch 31 at 4:38 PM | msn.comPACS Group, Inc. (NYSE:PACS) Receives $34.00 Consensus PT from AnalystsMarch 30 at 1:31 AM | americanbankingnews.comStock Traders Purchase High Volume of PACS Group Put Options (NYSE:PACS)March 29 at 3:17 AM | americanbankingnews.comPACS Group Inc options imply 5.0% move in share price post-earningsMarch 28, 2025 | markets.businessinsider.comSee More Headlines PACS Stock Analysis - Frequently Asked Questions How have PACS shares performed this year? PACS Group's stock was trading at $13.11 at the beginning of 2025. Since then, PACS shares have decreased by 17.4% and is now trading at $10.83. View the best growth stocks for 2025 here. How were PACS Group's earnings last quarter? PACS Group, Inc. (NYSE:PACS) released its earnings results on Monday, August, 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by $0.42. The business's quarterly revenue was up 29.1% on a year-over-year basis. When did PACS Group IPO? PACS Group (PACS) raised $450 million in an initial public offering (IPO) on Thursday, April 11th 2024. The company issued 21,428,572 shares at $21.00 per share. How do I buy shares of PACS Group? Shares of PACS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PACS Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that PACS Group investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings8/12/2024Today4/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Skilled nursing care facilities Sub-IndustryHealthcare Current SymbolNYSE:PACS Previous SymbolNYSE:PACS CIK2001184 Webpacs.com Phone801-447-9829FaxN/AEmployees32,433Year FoundedN/APrice Target and Rating Average Stock Price Target$34.00 High Stock Price Target$50.00 Low Stock Price Target$18.00 Potential Upside/Downside+213.9%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio10.72 P/E Growth0.49Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.82 Current Ratio1.71 Quick Ratio1.71 Sales & Book Value Annual Sales$3.56 billion Price / Sales0.46 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares152,400,000Free FloatN/AMarket Cap$1.65 billion OptionableOptionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NYSE:PACS) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.